Cite

MLA Citation

    D Money et al.. “Congenital anomalies following antenatal exposure to dolutegravir: a Canadian surveillance study.” BJOG, vol. 126, 2019, pp. 1338–1345. http://access.bl.uk/ark:/81055/vdc_100091313849.0x000020
  
Back to record